|
|
|
|
CelebrexHonolulu Star-Bulletin, Pfizer Inc., hampered by its warning that pain management drug Celebrex causes increased heart risks, lost 10.6 percent and was the worst performer among the ... Will cherry juice end pain of gout? 15 Jan 2006 Charlotte Observer, ...joint diminished also. I've been able to reduce my use of Celebrex from 400 mg/day to 200 mg/day and still have less pain.". Q. I ... Celebrex's Toughest Trial Dec 15, 2005 TIME A competitor made by Pfizer, Bextra, was yanked some months later, leaving only Pfizer's Celebrex behind—and a new, required safety warning hasn't exactly ... Pfizer sponsors major Celebrex safety study Dec 15, 2005 Pharma Times (subscription), Pfizer is gambling on a 20,000-patient study that it hopes will prove once and for all that its COX-2 inhibitor Celebrex (celecoxib) is effective and no more ... Does Celebrex Have A Future At All? Dec 20, 2005 Corante, I have a correspondent who's written me a few times about the Vioxx/Celebrex/NEJM situation, and I thought I'd pass along some of his thoughts. ... Saving Celebrex Dec 13, 2005 Forbes ...of academic researchers to meet with the US Food and Drug Administration to discuss a gigantic clinical trial to try to prove that low doses of Celebrex do not ... Pfizer's Search for an Answer on Celebrex Dec 13, 2005 BusinessWeek Pfizer (PFE ) is taking a big gamble in its bid to revive the beleaguered painkiller Celebrex. On Dec. 13, Dr. Steven E. Nissen ... Pfizer Plans Study of Celebrex for Heart Risks, Clinic Says Dec 13, 2005 Bloomberg ...will pay for a study of 20,000 patients to determine the potential heart risk of its Celebrex painkiller, a similar drug to Merck & Co.'s Vioxx, which was ... Pfizer Plans Study of 20,000 Patients on Risks of Celebrex Dec 13, 2005 New York Times, The study will compare the number of cardiovascular events, including heart attacks and strokes, in those taking Celebrex and two other commonly used ... Pfizer to Finance $100 Million Safety Study of Celebrex Dec 13, 2005 New York Times, By STEPHANIE SAUL. Pfizer, the pharmaceutical giant, is betting big on the safety of its cox-2 painkiller, Celebrex. The company ... Safety of Celebrex, other painkillers to be tested Dec 13, 2005 MSNBC That left Pfizer Inc.’s Celebrex as the only available cox-2 inhibitor, drugs that became blockbusters because they were gentler on the stomach than older ... Pfizer will fund clinic's study on heart risks of Celebrex Dec 13, 2005 Minneapolis Star Tribune (subscription), ...will pay for a study of 20,000 patients to determine the potential heart risk of its Celebrex painkiller, a similar drug to Merck & Company's Vioxx, which was ... Pfizer will fund study on safety of Celebrex Dec 14, 2005 International Herald Tribune, NEW YORK Pfizer, the pharmaceutical giant, is betting big on the safety of its cox-2 painkiller, Celebrex. The company has agreed ... Pfizer to fund independent trial on Celebrex and heart risks Dec 14, 2005 News-Medical.net, Drug company Pfizer Inc., the maker of Celebrex, will pay for an international study of 20,000 people. The study will compare the ... Pfizer Funds $100 Million Study On Cox-2 Inhibitors Celebrex Dec 14, 2005 Medical News Today, Pfizer, the makers of Celebrex, a cox-2 inhibitor for people with arthritis, is to fund a $100 million study into the safety of its own drug, Celebrex. ... Pfizer to fund safety study of Celebrex Dec 14, 2005 New Ratings Pharmaceutical giant Pfizer Inc (PFE.NYS) plans to finance a study of 20,000 patients to determine the potential heart risk of its cox-2 painkiller, Celebrex. ... An Expensive Way Back for Celebrex Dec 14, 2005 Corante, Pfizer's going to pull out the stops and spend up to $100 million to try to show that their COX-2 drug Celebrex is worth it. And ... Pfizer To Finance Long-Term Safety Study Of Celebrex Estimated To ... Dec 14, 2005 About - News & Issues, Pfizer, maker of the only remaining COX-2 inhibitor on the market in the United States, has announced it will finance a long-term safety study of Celebrex. ... Women sought in cancer study Jan 13, 2006 Cincinnati Enquirer, A national study sponsored by the National Cancer Institute aims to find out if the mechanism that allows celecoxib, or Celebrex, to ease pain by stopping ... What conventional and natural medicines have in common Jan 13, 2006 Australian, ...it is equally effective at relieving pain in this condition as the widely used non-steroidal anti-inflammatories like ibuprofen and the Cox-2 inhibitor Celebrex ... Study touts targeted drug ads Jan 11, 2006 Daily Pennsylvanian, One of its direct competitors, Celebrex, which works by the same mechanism, remains on the market but carries the Food and Drug Administration's most severe ... Pfizer is getting an overdose of generics Jan 8, 2006 Sun-Sentinel.com, ...remedies for common ailments. Among them were Celebrex for pain, Zoloft for depression and Viagra for impotence. Its key weapon ... Here we go, down the hole, chasing a Part D drug plan Jan 14, 2006 Newsday, But a 30-day supply of most brand-name maintenance drugs (such as Celebrex, Paxil, Lipitor, Cardizem and Pravachol) for which there are no generics, carries co ... Health Canada bans Bextra Jan 11, 2006 Quesnel Cariboo Observer, ...“The only one that’s left is Celebrex. ... Celebrex is not as strong as Vioxx, said Leung, and doesn’t cause as many problems if the correct dosage is taken. ... People's Pharmacy: Anti-inflammatory drugs may cause ... Jan 14, 2006 Bryan College Station Eagle, Drugs like Vioxx, Celebrex and Bextra were supposed to ease pain without causing the gastrointestinal problems associated with traditional NSAIDs. ... Strange Goings On at the Cleveland Clinic: Mere Coincidences or ... Dec 19, 2005 Newsinferno.com, Disclosures Cast Doubt on the World-Famous Clinic’s Reputation for Credibility and Independence as It Embarks on Pfizer’s $100 Million Celebrex Safety Study ... Drug's impact on cervical cancer studied Jan 11, 2006 Cincinnati Business Courier, ...cancer. A Phase 2 trial will test the effectiveness of celecoxib (Celebrex) in stopping the disease in its precancerous stage. The ... News and views Jan 10, 2006 The South African Journal of Natural Medicine (subscription), Vioxx has already been taken off the market, followed by Bextra, and even Celebrex is being fingered. None of this is surprising. ... Largest/Most Diverse Pipeline: Pfizer Jan 10, 2006 R&D Directions (subscription), ...emphasis on developing replacements. Under attack are market giants Lipitor, Viagra, Bextra, and Celebrex. Pfizer also strives to ... (PRN) Toward the Future of Cancer Prevention; Can Most Types of ... Dec 16, 2005 Houston Chronicle, Celecoxib, a non-steroidal anti-inflammatory drug (NSAID) known by the trade name Celebrex(r), reduced the number of colon polyps in people who have familial ... Can most types of cancers be prevented ? Dec 24, 2005 Xagena.it, Robert Bresalier helped lead this national effort. - Celecoxib, a non-steroidal anti-inflammatory drug ( NSAID ) known by the trade name Celebrex, reduced the ... New warning over arthritis drugs Jan 6, 2006 Daily Mail - UK, Since then similar doubts have been raised about another leading coxib, Celebrex, which was associated with a doubling of risk of major heart or artery ... Genes may explain some COX-2 drug risks Jan 4, 2006 MSNBC In April, Pfizer Inc. suspended sales of its COX-2 inhibitor Bextra and now includes a strong "black box" warning for its COX-2 Celebrex. ... Whirled Peas Jan 4, 2006 Neosho Daily News, Imagine my surprise when I got one from a law firm asking if I'd ever taken Bextra, Celebrex or Vioxx and experienced any number of side effects, including ... Problems with painkillers may be genetic Jan 4, 2006 United Press International A study, published in the January issue of the journal Gastroenterology, looked at people taking two popular painkillers -- Vioxx and Celebrex -- known as COX ... Genetics Plays Role in Side Effects Associated With Painkillers Jan 5, 2006 EndoNurse, The study looked at people taking two popular painkillers --rofecoxib (Vioxx, Merck) and celecoxib (Celebrex, Pfizer) -- known as COX-2 inhibitors. ... Pfizer funds $100M painkiller safety study Dec 15, 2005 myDNA.com, The study will assess Celebrex - Pfizer's Cox-2 inhibitor - and two non-steroidal anti-inflammatory drugs (NSAID's) - Ibuprofen and Naproxen. ... Major Painkiller Trial to Start Dec 15, 2005 ABC News The trial will focus on three drugs — ibuprofen (Advil/Motrin), naproxen (Naprosyn or Alleve) and celecoxib (Celebrex) — all of which belong to the class ... Stem Cell Project Scandal Is Disturbing but Hardly an Uncommon ... Dec 25, 2005 Newsinferno.com, Of the 32 government drug advisers who would vote on the issue, 10 had consulted for Merck (Vioxx) or Pfizer (Celebrex and Bextra) in recent years.While the ... Bird Flu Threat Tops Health News for '05 Dec 29, 2005 Forbes The US Food and Drug Administration allowed the third cox-2, Pfizer's Celebrex, to remain on the market, albeit with a strong "black-box" warning label ... Over-the-counter pain drugs increase death risk Dec 20, 2005 Macleans, Compared with people who did not take NSAIDs, those who took more than 200 milligrams a day of the COX-2 inhibitor Celebrex had four times the risk of dying. ... Clinical trial on painkillers Dec 20, 2005 The News Journal, The trial will focus on three drugs -- ibuprofen (Advil/Motrin), naproxen (Naprosyn or Aleve) and celecoxib (Celebrex) -- all of which belong to the class of ... Lipitor patent win boosts Pfizer shares Dec 19, 2005 BusinessWeek Lipitor isn't the only Pfizer product with an uncertain future. Sales of pain reliever Celebrex plunged 45 percent for the nine months to $1.3 billion. ... Scientists plan huge painkiller risk study Dec 14, 2005 Boston Globe, ...with heart risks -- people typically excluded from clinical trials -- around the globe to determine the safety and effectiveness of Celebrex, ibuprofen, and ... Health officials won't revive arthritis drug Dec 16, 2005 Toronto Star, ...in Canada. The drug falls into the same controversial class of drugs as Vioxx and Celebrex, known as cox-2 inhibitors. Vioxx, once ... `Good science' to study pain pills and heart woes Dec 15, 2005 Toronto Star, ...heart attack or stroke. That left Pfizer Inc.'s Celebrex as the only available cox-2 inhibitor available. The drugs became blockbusters ... Lessons from Vioxx Dec 19, 2005 Boston Globe, It would compete with Pfizer's Celebrex as a prescription medicine to relieve the pain of people with arthritis and other chronic pain conditions. ... Supplements help mend, not mask, pain Dec 20, 2005 Newsday, When top prescription pain relievers (like Vioxx or Bextra) are pulled from the market because of fatalities, and serious doubts shroud Celebrex and other ... Lipitor Patent Win Boosts Pfizer Shares Dec 19, 2005 Leading The Charge, Lipitor isn‘t the only Pfizer product with an uncertain future. Sales of pain reliever Celebrex plunged 45 percent for the nine months to $1.3 billion. ... Dow awakens, passes 11,000 Jan 9, 2006 Houston Chronicle, ...but a fair share of agitation about the company's expiring patents, a lack of new drugs, falling Viagra sales and safety concerns about painkiller Celebrex. ... Dow hits 11,000 in overdue catch-up Jan 10, 2006 Seattle Times, ...have had less drama but a fair share of worrying about expiring patents, a lack of new drugs, falling Viagra sales and safety concerns about painkiller Celebrex ... Bextra is latest cox-2 drug to be barred in Canada Dec 16, 2005 Hamilton Spectator (subscription), Better known cox-2s are Celebrex, which is still sold, and Vioxx, which was pulled from worldwide markets in late September 2004. ... Class Action Suit Says Depo-Provera Birth Control Drug Causes ... Dec 21, 2005 Lifesite, ...been filed against the drug company Pfizer, an international pharmaceutical conglomerate that also produces the prescription drugs Viagra, Zoloft and Celebrex. ... Top medical stories of 2005 Dec 30, 2005 WHDH-TV, Yet another arthritis drug bit the dust - Bextra was pulled after the FDA noted the medicine was no better than a similar drug Celebrex, and was more likely to ... Virginia's Ryan determined, defiant in long shadow of cancer Dec 26, 2005 WVEC.com (subscription), ...of her Charlottesville surgeon, Dr. Rayford Scott Jones; a hidden, benevolent quirk in her genetic makeup; the fact that she began taking Celebrex as a pain ... Dow index breaks 11,000 barrier Jan 10, 2006 San Francisco Chronicle, Both companies are beset by lawsuits -- Merck over Vioxx and Pfizer, to a lesser extent, over Celebrex -- and a desperate need to come up with new blockbuster ... Even at 11,000, old, gray Dow isn’t what it was Jan 10, 2006 TheNewsTribune.com (subscription), ...for investors who worry about the company’s expiring patents, a lack of new drugs, falling Viagra sales and safety concerns about painkiller Celebrex. ... Dow just 'catching up' Jan 10, 2006 Pioneer Press, ...have had less drama, but a fair share of agita, worrying about the company's expiring patents, a lack of new drugs and safety concerns about painkiller Celebrex ... Value stock manager trusts in Pfizer Dec 21, 2005 Dailyrecord.com, ..."Pfizer is remarkably cheap for a growth company.". What about the litigation about side effects of Celebrex? Pfizer isn't accused ... Dow hits 11,011.9, highest since ’01 Jan 10, 2006 Arkansas Democrat-Gazette (subscription), ...have had less drama, but worry about the company’s expiring patents, a lack of new drugs, falling Viagra sales and safety concerns about painkiller Celebrex. ... Pearls of Conventional Wisdom Jan 10, 2006 Smartmoney.com I've been wrong about pharmaceuticals before, but how can 2006 be worse than 2005, with its continuing fallout from the Vioxx and Celebrex debacles? ... Meghan Fitzgerald Joins Vion's Senior Management Team Jan 10, 2006 PR Newswire (press release), Management, where she led a team responsible for implementing a ten-year lifecycle plan for various pharmaceutical products including Celebrex, a multi-billion ... The Cox-2 Controversy: Health Risks of Arthritis Drugs Dec 13, 2005 The Lookout News, Millions of Americans live with the pain of arthritis and, until recently, painkillers such as Vioxx and Celebrex have been the modern remedy of choice. ... Cleveland Clinic To Lead Large Study on Safety, Efficacy of COX-2 ... Dec 14, 2005 Kaiser network.org, New York Times reports. Pfizer, which manufactures the COX-2 inhibitor Celebrex, will fund the study. According to Steven Nissen ... Pfizer gains on increase to dividend Dec 13, 2005 Providence Journal (subscription), Meanwhile, the drugmaker also says it will finance a study to determine the potential heart risk of Celebrex and two generic pain pills. ... Court Rules for Pfizer in Lipitor Patent Case Dec 17, 2005 All Headline News ...to a raft of problems. Sales of Pfizer’s Celebrex have been cut almost in half due to safety concerns. Revenue from Bextra was ... Bextra's return barred by Health Canada Dec 17, 2005 London Free Press, ...inhibitors. Better known cox-2s are Celebrex, which is still sold, and Vioxx, which was pulled from worldwide markets in September 2004. ... Medicare drug program just not healthy Dec 23, 2005 St. Louis Post-Dispatch, The cheapest price under any of the Medicare plans studied was 44 percent higher: $717. The VA paid $619 for a year's supply of Celebrex. ... Health Canada Bans Sale of Bextra Dec 18, 2005 Newsinferno.com, Pfizer has announced Celebrex is about to undergo new safety testing while the company’s other COX-2 inhibitor, Bextra, was removed from the market in April ... Dosage is key with acetaminophen Dec 16, 2005 Biloxi Sun Herald, A: Acetaminophen (Tylenol and other brands) is very safe when used properly. The Vioxx you took is a COX-2 NSAID (others are Bextra and Celebrex). ... Medical advances involve trade-offs Dec 16, 2005 Fort Wayne News Sentinel, ...over Vioxx. And Pfizer announced a major new study to determine whether its pain reliever, Celebrex, does or does not carry dangerous side effects. ... Painkiller Study Aims to Answer Safety Questions Dec 14, 2005 MedPage Today, The drugs are Celebrex (celecoxib), Motrin (ibuprofen) and Aleve (naproxen). The trial, which could cost $100 million, is being ... FDA Overlooking Serious Prescription Side Effects Dec 20, 2005 WLNS, ...for atopic dermatitis or psoriasis or other ecsema conditions like Elidel, the last being cox-two inhibitors, which are pain medications like Vioxx or Celebrex ... Alternative therapies offer headache relief Dec 23, 2005 myDNA.com, Though many factors have contributed to the rise in use, the controversy surrounding pain relief medications such as Celebrex and Vioxx certainly has some ... Study to test safety of painkillers on heart patients Dec 13, 2005 USA Today The study will pit Celebrex, naproxen and ibuprofen against one another in 20,000 patients in the USA, Canada, Latin America, Europe and Australia. ... iNOS-based inflammation pathway is cross-linked with COX-2 pathway Dec 27, 2005 Xagena.it, ...found to cross-link with the more well-known COX-2 pathway that is the target of COX-2 inhibitor drugs such as Vioxx ( Robecoxib ) and Celebrex ( Celecoxib ). ... Landmark study tests safety of painkillers Dec 14, 2005 DetNews.com, ...disease. Which drugs: Pfizer's Celebrex and over-the-counter ibuprofen (Motrin, Aleve) and naproxen (Naprosyn, Aleve) will be tested. ... Study aims to clear up confusion on painkillers Dec 13, 2005 Pittsburgh Post Gazette, The study will focus on the drugs Motrin, Advil, Naprosyn, Aleve and Celebrex. ... That left Celebrex as the only available Cox-2 inhibitor. ... Clinic-led trial to look at safety of painkillers Dec 14, 2005 Cleveland Plain Dealer, ...lead a worldwide clinical trial of about 20,000 patients to assess the safety of some of the most commonly used pain relievers: Motrin, Naprosyn and Celebrex. ... Study to weigh painkillers' safety Dec 14, 2005 Seattle Times, ...a heart attack or stroke. That left Pfizer's Celebrex as the only available Cox-2 inhibitor. Cox-2 inhibitors became blockbusters ... Researchers plan large-scale study on safety of painkillers Dec 13, 2005 WLNS, That leaves Celebrex as the only available cox-2 inhibitor. ... The study will test Celebrex and two types of drugs known as non-steroidal anti-inflammatory drugs. ... A large study will test the safety of various painkillers for ... Dec 13, 2005 FoxReno.com, ...risk of a heart attack or stroke. That leaves Celebrex as the only available cox-2 inhibitor. Those types of drugs became popular ... Clinic to lead trial of painkilling drugs Dec 13, 2005 Crain's Cleveland Business, Precision Trial, the study will examine the safety of ibuprofen, marketed as Motrin; naproxen, known as Naprosyn or Aleve; and celecoxib, also known as Celebrex ... Scientists searching for safe pain-relief drug Dec 13, 2005 WIS, Celebrex, Motrin and Aleve are three of the most common pain relievers for arthritis. ... Pfizer, which makes Celebrex, is paying for this study. ... Study on Safety of Pain Killers Dec 14, 2005 WLNS, Drugs like Vioxx, Bextra and Celebrex became popular because they were gentler on the stomach than older pain relievers, but those drugs have been at the ... Bird Flu, Cloning, Katrina: Top Health Stories of 2005 Dec 27, 2005 FOX News ...off the market. That leaves only Celebrex to represent the new class of pain pills once billed as "super aspirin.". These drugs, known ... Breakthroughs, tips and trends Jan 6, 2006 Times Online, ...in the British Medical Journal, indicated that long-term use of the two drugs examined in the Pennsylvania report, Vioxx and Celebrex, increases the risk by 32 ... Getting the Specifics on Generic Drugs Jan 5, 2006 Forbes In contrast, Celebrex -- the remaining cox-2 inhibitor painkiller on the US market -- "has a lot of time left" on its patent, he said. ... ADHD Drug Cardiac Events, COX-2s Are Topics For Drug Safety ... Jan 5, 2006 FDA Advisory Committee Bextra in April. Pfizer’s other COX-2 product Celebrex has remained on the market with added warnings to labeling. The committee ... Post-marketing drug studies become norm Dec 26, 2005 Fort Wayne Journal Gazette, Pfizer is paying for a study to determine whether its pain reliever Celebrex leads to more heart problems than other pain relievers. ... Ages change for assistance Jan 6, 2006 Scottsboro Daily Sentinel, Senior Rx often helps facilitate savings for the purchase of drugs like Celebrex, Mobic, Toprol, Norvasc, Nexium, and Prevacaid. ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |